NEW YORK (GenomeWeb News) - Roche Diagnostics today said it has signed a licensing agreement with Multilyte for access to Multilyte's patents for diagnostic assays.
Roche will pay a license fee and royalties from the sale of products covered by Multilyte’s patents.
Assays covered under the patents include mulitparameter binding assays, including immunoassays, to enable “simultaneous detection and analysis of many different analytes in small test samples of biological origin,” Roche said.
Roche said that the agreement will enable it to develop microarray-based immunoassays and other binding assay systems that will detect multiple analytes in a single reaction.
Multilyte was founded in 1988 as a spin-off from University College London by UCL biophysics professor Roger Ekins.